Acid suppression and gastric mucosal cell biology

G. Delle Fave, H. Helander, S. Holt, I. M. Modlin, R. Powers, E. Solcia, A. Soll, Y. Tielemans, N. A. Wright

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

This review examines recent concepts of gastric mucosal cell biology in relation to acid inhibition. Powerful acid-inhibitory drugs have been associated with the production of enterochromaffin-like (ECL) cell proliferation and the induction of ECL cell carcinoids in rats. The ECL cell lineage and its renewal is discussed, and the factors that regulate ECL-cell proliferation are reviewed. Current methods in use for assessing genotoxicity in gastric mucosa are scrutinized; the much discussed claim that antisecretory drugs induce unscheduled DNA synthesis is examined, and the methodology that is the basis for these claims is found defective and wanting. The nature of ECL cell proliferation in rats receiving lifelong treatment with H2-receptor antagonists or acid pump inhibitors is explored, and their relationship to ECL cell proliferation and ECL cell carcinoids discussed. It is concluded that aged rats are very prone to developing endocrine proliferations, and this may be related to the multiple endocrine neoplasia syndrome found in humans. There is no evidence at present that long-term antisecretory therapy causes significant ECL cell proliferation in humans.

Original languageEnglish
JournalDigestive Diseases and Sciences
Volume40
Issue number2 Supplement
DOIs
Publication statusPublished - Feb 1995

Fingerprint

Enterochromaffin-like Cells
Gastric Acid
Cell Biology
Cell Proliferation
Carcinoid Tumor
Acids
Multiple Endocrine Neoplasia
Histamine H2 Receptors
Cell Lineage
Gastric Mucosa
Pharmaceutical Preparations
Stomach

Keywords

  • acid suppression
  • enterochromaffin-like cells
  • gastric carcinoids
  • gastric mucosa
  • intestinal metaplasia
  • multiple endocrine neoplasia syndrome
  • unscheduled DNA synthesis

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Fave, G. D., Helander, H., Holt, S., Modlin, I. M., Powers, R., Solcia, E., ... Wright, N. A. (1995). Acid suppression and gastric mucosal cell biology. Digestive Diseases and Sciences, 40(2 Supplement). https://doi.org/10.1007/BF02214875

Acid suppression and gastric mucosal cell biology. / Fave, G. Delle; Helander, H.; Holt, S.; Modlin, I. M.; Powers, R.; Solcia, E.; Soll, A.; Tielemans, Y.; Wright, N. A.

In: Digestive Diseases and Sciences, Vol. 40, No. 2 Supplement, 02.1995.

Research output: Contribution to journalArticle

Fave, GD, Helander, H, Holt, S, Modlin, IM, Powers, R, Solcia, E, Soll, A, Tielemans, Y & Wright, NA 1995, 'Acid suppression and gastric mucosal cell biology', Digestive Diseases and Sciences, vol. 40, no. 2 Supplement. https://doi.org/10.1007/BF02214875
Fave GD, Helander H, Holt S, Modlin IM, Powers R, Solcia E et al. Acid suppression and gastric mucosal cell biology. Digestive Diseases and Sciences. 1995 Feb;40(2 Supplement). https://doi.org/10.1007/BF02214875
Fave, G. Delle ; Helander, H. ; Holt, S. ; Modlin, I. M. ; Powers, R. ; Solcia, E. ; Soll, A. ; Tielemans, Y. ; Wright, N. A. / Acid suppression and gastric mucosal cell biology. In: Digestive Diseases and Sciences. 1995 ; Vol. 40, No. 2 Supplement.
@article{e7a2bdb7f12144419f80876557e3f52c,
title = "Acid suppression and gastric mucosal cell biology",
abstract = "This review examines recent concepts of gastric mucosal cell biology in relation to acid inhibition. Powerful acid-inhibitory drugs have been associated with the production of enterochromaffin-like (ECL) cell proliferation and the induction of ECL cell carcinoids in rats. The ECL cell lineage and its renewal is discussed, and the factors that regulate ECL-cell proliferation are reviewed. Current methods in use for assessing genotoxicity in gastric mucosa are scrutinized; the much discussed claim that antisecretory drugs induce unscheduled DNA synthesis is examined, and the methodology that is the basis for these claims is found defective and wanting. The nature of ECL cell proliferation in rats receiving lifelong treatment with H2-receptor antagonists or acid pump inhibitors is explored, and their relationship to ECL cell proliferation and ECL cell carcinoids discussed. It is concluded that aged rats are very prone to developing endocrine proliferations, and this may be related to the multiple endocrine neoplasia syndrome found in humans. There is no evidence at present that long-term antisecretory therapy causes significant ECL cell proliferation in humans.",
keywords = "acid suppression, enterochromaffin-like cells, gastric carcinoids, gastric mucosa, intestinal metaplasia, multiple endocrine neoplasia syndrome, unscheduled DNA synthesis",
author = "Fave, {G. Delle} and H. Helander and S. Holt and Modlin, {I. M.} and R. Powers and E. Solcia and A. Soll and Y. Tielemans and Wright, {N. A.}",
year = "1995",
month = "2",
doi = "10.1007/BF02214875",
language = "English",
volume = "40",
journal = "Digestive Diseases and Sciences",
issn = "0163-2116",
publisher = "Springer New York",
number = "2 Supplement",

}

TY - JOUR

T1 - Acid suppression and gastric mucosal cell biology

AU - Fave, G. Delle

AU - Helander, H.

AU - Holt, S.

AU - Modlin, I. M.

AU - Powers, R.

AU - Solcia, E.

AU - Soll, A.

AU - Tielemans, Y.

AU - Wright, N. A.

PY - 1995/2

Y1 - 1995/2

N2 - This review examines recent concepts of gastric mucosal cell biology in relation to acid inhibition. Powerful acid-inhibitory drugs have been associated with the production of enterochromaffin-like (ECL) cell proliferation and the induction of ECL cell carcinoids in rats. The ECL cell lineage and its renewal is discussed, and the factors that regulate ECL-cell proliferation are reviewed. Current methods in use for assessing genotoxicity in gastric mucosa are scrutinized; the much discussed claim that antisecretory drugs induce unscheduled DNA synthesis is examined, and the methodology that is the basis for these claims is found defective and wanting. The nature of ECL cell proliferation in rats receiving lifelong treatment with H2-receptor antagonists or acid pump inhibitors is explored, and their relationship to ECL cell proliferation and ECL cell carcinoids discussed. It is concluded that aged rats are very prone to developing endocrine proliferations, and this may be related to the multiple endocrine neoplasia syndrome found in humans. There is no evidence at present that long-term antisecretory therapy causes significant ECL cell proliferation in humans.

AB - This review examines recent concepts of gastric mucosal cell biology in relation to acid inhibition. Powerful acid-inhibitory drugs have been associated with the production of enterochromaffin-like (ECL) cell proliferation and the induction of ECL cell carcinoids in rats. The ECL cell lineage and its renewal is discussed, and the factors that regulate ECL-cell proliferation are reviewed. Current methods in use for assessing genotoxicity in gastric mucosa are scrutinized; the much discussed claim that antisecretory drugs induce unscheduled DNA synthesis is examined, and the methodology that is the basis for these claims is found defective and wanting. The nature of ECL cell proliferation in rats receiving lifelong treatment with H2-receptor antagonists or acid pump inhibitors is explored, and their relationship to ECL cell proliferation and ECL cell carcinoids discussed. It is concluded that aged rats are very prone to developing endocrine proliferations, and this may be related to the multiple endocrine neoplasia syndrome found in humans. There is no evidence at present that long-term antisecretory therapy causes significant ECL cell proliferation in humans.

KW - acid suppression

KW - enterochromaffin-like cells

KW - gastric carcinoids

KW - gastric mucosa

KW - intestinal metaplasia

KW - multiple endocrine neoplasia syndrome

KW - unscheduled DNA synthesis

UR - http://www.scopus.com/inward/record.url?scp=0028853447&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028853447&partnerID=8YFLogxK

U2 - 10.1007/BF02214875

DO - 10.1007/BF02214875

M3 - Article

AN - SCOPUS:0028853447

VL - 40

JO - Digestive Diseases and Sciences

JF - Digestive Diseases and Sciences

SN - 0163-2116

IS - 2 Supplement

ER -